Thrombosis and Haemostasis

LinksSchließen

Referenz

Kaufman JL, Niesvizky R, Stadtmauer EA. , et al.
Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma.

Br J Haematol 2013;
163 (04) 478-486

Bibliographische Angaben herunterladen

Aufrufen in: